Hirsh, Vera : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (94)
Les plus populaires
Liste
- Liste
- Tableau

1

Afatinib as First-line Treatment of Older Patients with EGFR Mutation-positive Non-small-cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6 and LUX-Lung 7 Trials

Wu, Yi-Long, Sequist, Lecia V., Tan, Eng-Huat, Geater, Sarayut L., Orlov, Sergey, Zhang, Li, Lee, Ki Hyeong, Tsai, Chun-Ming, Kato, Terufumi, Barrios, Carlos H., Schuler, Martin, Hirsh, Vera, Yamamoto

Journal:

Clinical Lung Cancer

Année:

2018

Langue:

english

Fichier:

PDF, 9.50 MB

english, 2018

2

Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma

Roger von Moos, David Henry, Saroj Vadhan-Raj, Vania Hungria, Andrew Spencer, Vera Hirsh, Jianming Wang, Jun Susie, Yeh Howard, Roger Dansey

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 58 KB

english, 2010

3

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Edward S Kim, Vera Hirsh, Tony Mok, Mark A Socinski, Radj Gervais, Yi-Long Wu, Long-Yun Li, Claire L Watkins, Mark V Sellers, Elizabeth S Lowe, Yan Sun, Mei-Lin Liao, Kell Østerlind, Martin Reck, Alis

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 243 KB

english, 2008

4

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Park, Keunchil, Tan, Eng-Huat, O'Byrne, Ken, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Yang, James Chih-Hsin, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa, Kim, Dong-

Journal:

The Lancet Oncology

Année:

2016

Langue:

english

Fichier:

PDF, 524 KB

english, 2016

5

First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression

Schuler, Martin, Tan, Eng-Huat, O’Byrne, Kenneth, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Yang, James Chih-Hsin, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa, Kim,

Journal:

Journal of Cancer Research and Clinical Oncology

Année:

2019

Fichier:

PDF, 1.92 MB

2019

6

Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer

Nair, Jay Kumar Raghavan, Saeed, Umar Abid, McDougall, Connor C., Sabri, Ali, Kovacina, Bojan, Raidu, B. V. S., Khokhar, Riaz Ahmed, Probst, Stephan, Hirsh, Vera, Jeffrey, Chankowsky, Van Kempen, LÃ©o

Journal:

Canadian Association of Radiologists Journal

Année:

2020

Langue:

english

Fichier:

PDF, 574 KB

english, 2020

7

Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B

Frederick Richards Ii, David J. Perry, Maria Goutsou, Caron Modeas, Elaine Muchmore, Mark R. Green, Vishram Rege, A. Philippe Chahinian, Vera Hirsh, Bernard Poiesz

Journal:

Année:

1991

Langue:

english

Fichier:

PDF, 569 KB

english, 1991

8

Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma : A Phase II multicenter trial

Vera Hirsh, Adrian Langleben, Joseph Ayoub, Yvon Cormier, Javier Pintos, José L. Iglésias

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 85 KB

english, 2001

9

Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC) : A dose-optimizing phase II trial

Vera Hirsh, Renaud Whittom, Linda Ofiara, Pierre Desjardins, Joseph Ayoub, Danielle Charpentier, David Small, Javier Pintos, Adrian Langleben

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 84 KB

english, 2003

10

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : A randomized, Phase III, double-blind, placebo-controlled trial

Lee S. Rosen, David Gordon, N. Simon Tchekmedyian, Ronald Yanagihara, Vera Hirsh, Maciej Krzakowski, Marek Pawlicki, Paul de Souza, Ming Zheng, Gladys Urbanowitz, Dirk Reitsma, John Seaman, On behalf

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 161 KB

english, 2004

11

Zoledronic acid use in cancer patients : More than just supportive care?

Robert Coleman, Richard Cook, Vera Hirsh, Pierre Major, Allan Lipton

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 275 KB

english, 2011

12

Phase II trial of 4′-deoxydoxorubicin (DxDx) in non-small cell lung cancer: A cancer and leukemia group B trial

Q. Scott Ringenberg, Michael C. Perry, Kathleen J. Propert, Caron Modeas, Vera Hirsh, Raymond B. Weiss, Frederick Richards II, Stephen Graziano, Mark Green

Journal:

Pediatric Blood & Cancer

Année:

1988

Langue:

english

Fichier:

PDF, 225 KB

english, 1988

13

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy

Vera Hirsh, John Glaspy, Paul Mainwaring, Christian Manegold, Rodryg Ramlau, Joseph E Eid

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 327 KB

english, 2007

14

Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates

Rebecca Aft, Jose-Ricardo Perez, Noopur Raje, Vera Hirsh, Fred Saad

Journal:

Critical Reviews in Oncology/Hematology

Année:

2012

Langue:

english

Fichier:

PDF, 716 KB

english, 2012

15

Bisphosphonates in Lung Cancer: More Than a Palliative Therapy?

Mohammad Jahanzeb, Vera Hirsh

Journal:

Seminars in Oncology

Année:

2010

Langue:

english

Fichier:

PDF, 226 KB

english, 2010

16

Emerging Safety Data for Bevacizumab in Advanced Non–Small-Cell Lung Cancer

Journal:

Clinical Lung Cancer

Année:

2008

Langue:

english

Fichier:

PDF, 155 KB

english, 2008

17

Skeletal Disease Contributes Substantially to Morbidity and Mortality in Patients with Lung Cancer

Journal:

Clinical Lung Cancer

Année:

2009

Langue:

english

Fichier:

PDF, 135 KB

english, 2009

18

Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation

Ori Rogowski, Yaffa Vered, Itzhak Shapira, Meirav Hirsh, Vera Zakut, Shlomo Berliner

Journal:

Clinica Chimica Acta

Année:

2005

Langue:

english

Fichier:

PDF, 157 KB

english, 2005

19

P81. Meta-analysis of effects of zoledronic acid (ZOL) on survival in patients with metastatic bone disease (MBD) and high bone turnover

Robert Coleman, Richard Cook, Fred Saad, Vera Hirsh, Pierre Major, Rosh Dias, Allan Lipton

Journal:

Cancer Treatment Reviews

Année:

2008

Langue:

english

Fichier:

PDF, 27 KB

english, 2008

20

P79. N-Telopeptide of type I collagen (NTX) levels and prognosis in patients with bone metastases from non-small cell lung cancer (NSCLC) receiving zoledronic acid (ZOL) or placebo

Vera Hirsh, Pierre Major, Allan Lipton, Richard Cook, Corey Langer, Matthew Smith, Janet Brown, Robert Coleman

Journal:

Cancer Treatment Reviews

Année:

2008

Langue:

english

Fichier:

PDF, 32 KB

english, 2008

21

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

Vincent A Miller, Vera Hirsh, Jacques Cadranel, Yuh-Min Chen, Keunchil Park, Sang-We Kim, Caicun Zhou, Wu-Chou Su, Mengzhao Wang, Yan Sun, Dae Seog Heo, Lucio Crino, Eng-Huat Tan, Tsu-Yi Chao, Mehdi S

Journal:

The Lancet Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 373 KB

english, 2012

22

P-676 Long-term therapy with zoledronic acid is effective and safe in reducing the risk of skeletal complications in patients with bone metastases from non-small cell lung cancer

Bukowski, Ronald, Rosen, Lee S., Gordon, David, Tchekmedyian, Simon, Hirsh, Vera, Yanagihara, Ronald, Coleman, Robert E.

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 365 KB

english, 2003

23

Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Silvia Novello, Joan H. Schiller, Vera Hirsh, Lecia V. Sequist, Jean-Charles Soria, Joachim von Pawel, Brian Schwartz, Reinhard Von Roemeling, Alan B. Sandler

Journal:

Clinical Lung Cancer

Année:

2012

Langue:

english

Fichier:

PDF, 332 KB

english, 2012

24

Docetaxel and Gemcitabine administered on days 1 and 8 for metastatic non-small cell lung carcinoma (NSCLC): a phase II multicenter trial

Hirsh, Vera, Whittom, R., Desjardins, P., Laberge, F., Latreille, J., Samson, B., Langleben, A.

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 93 KB

english, 2004

25

Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities—a multicenter phase II trial

Hirsh, Vera, Latreille, Jean, Kreisman, Harvey, Desjardins, Pierre, Ofiara, Linda, Whittom, Renaud, Fox, Susan, Palayew, Mark David, Pintos, Javier

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 121 KB

english, 2005

26

Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonates

Langer, Corey, Hirsh, Vera

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 229 KB

english, 2010

27

LUX-lung 3: A randomized, open-label, phase III study of afatinib vs pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations

Schuler, Martin, Yang, James Chih-Hsin, Yamamoto, Nobuyuki, O’Byrne, Ken, Hirsh, Vera, Mok, Tony, Massey, Dan, Zazulina, Victoria, Shahidi, Mehdi, Sequist, Lecia

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 53 KB

english, 2012

28

An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases

Sandler, Alan, Hirsh, Vera, Reck, Martin, von Pawel, Joachim, Akerley, Wallace, Johnson, David H.

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 243 KB

english, 2012

29

Clinical Benefit of Zoledronic Acid in Patients with Lung Cancer and OtherSolid Tumors: Analysis Based on History of Skeletal Complications

Vera Hirsh, N. Simon Tchekmedyian, Lee S. Rosen, Ming Zheng, Yong-Jiang Hei

Journal:

Clinical Lung Cancer

Année:

2004

Langue:

english

Fichier:

PDF, 134 KB

english, 2004

30

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

Shepherd, Frances A., Rodrigues Pereira, José, Ciuleanu, Tudor, Tan, Eng Huat, Hirsh, Vera, Thongprasert, Sumitra, Campos, Daniel, Maoleekoonpiroj, Savitree, Smylie, Michael, Martins, Renato, van Koot

Journal:

Boston Medical and Surgical Journal

Année:

2005

Langue:

english

Fichier:

PDF, 269 KB

english, 2005

31

A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium

Laurie, Scott A., Goss, Glenwood D., Shepherd, Frances A., Reaume, M. Neil, Nicholas, Garth, Philip, Lindsay, Wang, Lisa, Schwock, Joerg, Hirsh, Vera, Oza, Amit, Tsao, Ming-Sound, Wright, John J., Lei

Journal:

Clinical Lung Cancer

Année:

2014

Langue:

english

Fichier:

PDF, 205 KB

english, 2014

32

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors

Henry, David, Vadhan-Raj, Saroj, Hirsh, Vera, Moos, Roger, Hungria, Vania, Costa, Luis, Woll, Penella J, Scagliotti, Giorgio, Smith, Geoffrey, Feng, Amy, Jun, Susie, Dansey, Roger, Yeh, Howard

Journal:

Supportive Care in Cancer

Année:

2014

Langue:

english

Fichier:

PDF, 315 KB

english, 2014

33

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)

Reaume, M. Neil, Leighl, Natasha B., Mittmann, Nicole, Coyle, Doug, Hirsh, Vera, Seymour, Lesley, Tu, Dongsheng, Shepherd, Frances A., Graham, Barbara, Gridelli, Cesare, Perrone, Francesco, Di Maio, M

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 589 KB

english, 2013

34

Conclusion

Journal:

Journal of Infection and Public Health

Année:

2012

Langue:

english

Fichier:

PDF, 121 KB

english, 2012

35

Introduction from the Guest Editor

Journal:

Journal of Infection and Public Health

Année:

2012

Langue:

english

Fichier:

PDF, 138 KB

english, 2012

36

Functions of Interleukin 1 Receptor Antagonist in Gene Knockout and Overproducing Mice

Emmet Hirsch, Vera M. Irikura, Sarah M. Paul and David Hirsh

Journal:

Proceedings of the National Academy of Sciences

Année:

1996

Langue:

english

Fichier:

PDF, 1.47 MB

english, 1996

37

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment

Langer, Corey J., Hirsh, Vera, Ko, Amy, Renschler, Markus F., Socinski, Mark A.

Journal:

Clinical Lung Cancer

Année:

2015

Langue:

english

Fichier:

PDF, 334 KB

english, 2015

38

Afatinib (BIBW 2992) development in non-small-cell lung cancer

Journal:

Future Oncology

Année:

2011

Langue:

english

Fichier:

PDF, 373 KB

english, 2011

39

Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung Cancer

Hirsh, Vera, Okamoto, Isamu, Hon, Jeremy K., Page, Ray D., Orsini, James, Sakai, Hiroshi, Zhang, Hui, Renschler, Markus F., Socinski, Mark A.

Journal:

Journal of Thoracic Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 499 KB

english, 2014

40

Patient-Reported Outcomes and Quality of Life in PROFILE 1007

Blackhall, Fiona, Kim, Dong-Wan, Besse, Benjamin, Nokihara, Hiroshi, Han, Ji-Youn, Wilner, Keith D., Reisman, Arlene, Iyer, Shrividya, Hirsh, Vera, Shaw, Alice T.

Journal:

Journal of Thoracic Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 1.28 MB

english, 2014

41

Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer

Jänne, Pasi A., Paz-Ares, Luis, Oh, Yun, Eschbach, Corinna, Hirsh, Vera, Enas, Nathan, Brail, Leslie, von Pawel, Joachim

Journal:

Journal of Thoracic Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 329 KB

english, 2014

42

nab -paclitaxel for the management of patients with advanced non-small-cell lung cancer

Journal:

Expert Review of Anticancer Therapy

Année:

2014

Langue:

english

Fichier:

PDF, 521 KB

english, 2014

43

Chemotherapy in Metastatic NSCLC â€“ New Regimens (Pemetrexed, Nab-Paclitaxel)

Blais, Normand, Hirsh, Vera

Journal:

Frontiers in Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 389 KB

english, 2014

44

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine

Journal:

Frontiers in Oncology

Année:

2015

Langue:

english

Fichier:

PDF, 749 KB

english, 2015

45

Targeted Treatments of Bone Metastases in Patients with Lung Cancer

Journal:

Frontiers in Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 600 KB

english, 2014

46

Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?

Journal:

Frontiers in Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 386 KB

english, 2014

47

Management of Common Toxicities in Metastatic NSCLC Related to Anti-Lung Cancer Therapies with EGFRâ€“TKIs

Melosky, Barbara, Hirsh, Vera

Journal:

Frontiers in Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 944 KB

english, 2014

48

A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer

Ellis, Peter M., Leighl, Natasha B., Hirsh, Vera, Reaume, M. Neil, Blais, Normand, Wierzbicki, Rafal, Sadrolhefazi, Behbood, Gu, Yu, Liu, Dan, Pilz, Korinna, Chu, Quincy

Journal:

Clinical Lung Cancer

Année:

2015

Langue:

english

Fichier:

PDF, 761 KB

english, 2015

49

Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.05 MB

english, 2015

50

Bisphosphonates in Lung Cancer: Can They Provide Benefits Beyond Prevention of Skeletal Morbidity?

Journal:

Anti-Cancer Agents in Medicinal Chemistry

Année:

2012

Langue:

english

Fichier:

PDF, 159 KB

english, 2012